AMIVAS IRELAND LIMITED

Overview

AMIVAS Ireland Limited is a pharmaceutical company focused on the development, commercialization, and distribution of Artesunate, a life-saving treatment for severe malaria. The company operates as a US, Australian, and European joint venture with manufacturing in North America and distribution partners in Canada, the USA, and Europe. It has offices in Ireland and is committed to supplying critical medicines to hospitals and patients in need. AMIVAS launched Europe’s first and only licensed severe malaria treatment, following FDA approval of its first product in 2020. The company’s mission includes advancing scientific discovery and providing effective, fast-acting treatments for life-threatening diseases. The name suggests a focus on global health and infectious disease therapeutics, with operations spanning multiple continents. Beyond registry-level identification, no further business details are publicly captured.

Location & registered address

Suite 5

Station House

Railway Square

Waterford

Ireland

Industry classification

NACE Rev. 2 — 64.20

→ All NACE 64.20 companies in Ireland · In Waterford